25:
371:
Pennington SH, Pojar S, Mitsi E, Gritzfeld JF, Nikolaou E, Solórzano C, Owugha JT, Masood Q, Gordon MA, Wright AD, Collins AM, Miyaji EN, Gordon SB, Ferreira DM. Polysaccharide-specific Memory B-cells
Predict Protection Against Experimental Human Pneumococcal Carriage. Am J Respir Crit Care Med. 2016
340:
Mitsi. E, Carniel.B, Reiné.J, Rylance.J, Zaidi. S, Soares-Schanos.A, Connor. V, Collins. A, Schlitzer. A, Nikolaou. E, SolorzanoGonzalez. C, Pojar. S , Hill. H, Hyder-Wright. A, Jambo. K , Oggioni. M. De Ste Croix, Megan, Gordon.S, Jochems.S, and
Ferreira. DM. Nasal Pneumococcal Density is Associated
336:
Adler H, German EL, Mitsi E, Nikolaou E, Pojar S, Hales C, Robinson R, Connor V, Hill H, Hyder-Wright AD, Lazarova L, Lowe C, Smith EL, Wheeler I, Zaidi SR, Jochems SP, Loukov D, Reiné J, Solórzano-Gonzalez C, de
Gorguette d'Argoeuves P, Jones T, Goldblatt D, Chen T, Aston SJ, French N, Collins AM,
363:
Jochems SP, Marcon F, Carniel BF, Zaidi S, Piddock K, Wheeler I, Gordon SB, Rylance J, Nakaya H, Ferreira DM. Inflammation induced by influenza virus impairs innate control of human pneumococcal carriage. Nature
Immunology. 2018 Dec;19(12):1299-1308. doi: 10.1038/s41590-018-0231-y. Epub 2018 Oct
348:
Jochems S, K.de Ruiter, C.Solórzano, A. Voskamp, E.Mitsi, E.Nikolaou, B.Carniel, S. Pojar, E.German, J. Reiné, A. Soares-Schanoski, H. Hill, R.Robinson, A. Hyder-Wright, C. M. Weight, P.F. Durrenberger, R.S. Heyderman, S. B. Gordon, H. H. Smits, B.C. Urban, J. Rylance, A.. Collins, M. D. Wilkie,
383:
Ferreira DM, Neill DR, Bangert M, Gritzfeld JF, Green N, Wright AK, Pennington SH, Moreno LB, Moreno AT, Miyaji EN, Wright AD, Collins AM, Goldblatt D, Kadioglu A, Gordon SB. Controlled Human
Infection and Re-Challenge with Streptococcus Pneumoniae Reveals the Protective Efficacy of Carriage in
379:
Glennie S, Gritzfeld JF, Pennington SH, Garner-Jones M, Coombes N, Hopkins MJ, Vadesilho CF, Miyaji EN, Wang D, Wright AD, Collins AM, Gordon SB, Ferreira DM. Modulation of nasopharyngeal innate defenses by viral coinfection predisposes individuals to experimental pneumococcal carriage. Mucosal
375:
E Mitsi, AM Roche, J Reiné, T Zangari, JT Owugha1, SH Pennington, JF Gritzfeld, AM Collins, S van Selm, MI de Jonge, SB Gordon, JN Weiser, DM Ferreira. Agglutination by anti-capsular polysaccharide antibody is associated with protection against experimental human pneumococcal carriage. Mucosal
811:
De
Steenhuijsen Piters, Wouter A. A.; Jochems, Simon P.; Mitsi, Elena; Rylance, Jamie; Pojar, Sherin; Nikolaou, Elissavet; German, Esther L.; Holloway, Mark; Carniel, Beatriz F.; Chu, Mei Ling J. N.; Arp, Kayleigh; Sanders, Elisabeth A. M.; Ferreira, Daniela M.; Bogaert, Debby (2019).
87:
231:. She leads a team of scientists studying protective immune responses against pneumococcus and other respiratory pathogens such as SARS-CoV2. Her team has established a novel method of inducing pneumococcal carriage in human volunteers. They use this model to:
367:
Rylance J, de
Steenhuijsen Piters WAA, Mina MJ, Bogaert D, French N, Ferreira DM; and the EHPC-LAIV study group. Two Randomized Trials of Effect of Live Attenuated Influenza Vaccine on Pneumococcal Colonization. Am J Respir Crit Care Med. 2019 Feb 13. doi:
337:
Gordon SB, J*Rylance
Ferreira DM*. Experimental Human Pneumococcal Colonization in Older Adults Is Feasible and Safe, Not Immunogenic. Am J Respir Crit Care Med. 2021 Mar 1;203(5):604-613. doi: 10.1164/rccm.202004-1483OC. PMID 32941735; PMCID: PMC7924584.
515:
299:
led the development of an
Experimental Human Pneumococcal Nasopharyngeal Colonization Model. Ferreira was appointed Professor and subsequent Head of Department of Clinical Sciences in 2018. Her main lines of research are:
633:
349:
L.Lazarova, S.C. Leong, M.Yazdanbakhsh, Ferreira DM. Innate and adaptive nasal mucosal immune responses following experimental human pneumococcal colonization, J Clin Invest. 2019, Oct;129(10):4523-4538.
563:
264:
Ferreira is part of the HIC-VAC consortium and Leads the WorkStream on Human
Challenge Plataform to accelerate product development in the UKRI Infection Innovation Consortium (iiCON).
1196:
537:
352:
Steenhuijsen Piters WAA, Jochems S, Mitsi E, Rylance J, Pojar S, Nikolaou E, German EL, Holloway M, Carniel BF, Chu MLJN, Arp K,. Sanders EAM, Ferreira DM* and
191:
711:"Nasal Pneumococcal Density is Associated with Microaspiration and Heightened Human Alveolar Macrophage Responsiveness to Bacterial Pathogens"
288:
236:
228:
174:
1126:"Controlled Human Infection and Re-Challenge with Streptococcus Pneumoniae Reveals the Protective Efficacy of Carriage in Healthy Adults"
356:* Interaction between live-attenuated influenza vaccine, Streptococcus pneumoniae and the nasal microbiota. Nat Commun. 10, 2981 (2019),
341:
with Microaspiration and Heightened Human Alveolar Macrophage Responsiveness to Bacterial Pathogens. Am J Respir Crit Care Med. Oct 2019.
455:
1024:"Agglutination by anti-capsular polysaccharide antibody is associated with protection against experimental human pneumococcal carriage"
634:"Pneumococcus Human Infection Challenge and the Effect of Respiratory Virus Co-infections on Mucosal Immunity – Prof Daniela Ferreira"
192:
DNA vaccines against Streptococcus pneumoniae based on PspA (Pneumococcal surface protein A) and PspC (Pneumococcal surface protein C)
311:
2) Understanding nasal and lung immune responses and correlates of protection against respiratory infection with viruses including
1186:
1075:"Modulation of nasopharyngeal innate defenses by viral coinfection predisposes individuals to experimental pneumococcal carriage"
402:
1191:
152:
277:
126:
121:
814:"Interaction between the nasal microbiota and S. Pneumoniae in the context of live-attenuated influenza vaccine"
296:
973:"Polysaccharide-specific Memory B-cells Predict Protection Against Experimental Human Pneumococcal Carriage"
762:"Innate and adaptive nasal mucosal immune responses following experimental human pneumococcal colonization"
564:"Brasileira que coordena testes com vacina para Covid-19 na Inglaterra explica dilema da prova de eficácia"
1181:
257:
Her team has played a substantial role in the UK covid-19 pandemic response as a trial site for several
825:
224:
220:
170:
660:"Experimental Human Pneumococcal Colonization in Older Adults Is Feasible and Safe, Not Immunogenic"
922:"Two Randomized Trials of Effect of Live Attenuated Influenza Vaccine on Pneumococcal Colonization"
292:
219:
and vaccine responses. She is currently Professor of Respiratory Infection and Vaccinology at the
318:
3) Defining how respiratory virus co-infections (flu, RSV and SARS-CoV2) and host susceptibility (
35:
216:
178:
239:) make responses to respiratory bacteria and virus and how this is different from healthy people
871:"Inflammation induced by influenza virus impairs innate control of human pneumococcal carriage"
272:
Ferreira obtained a Degree and Bachelor's Degree in Biological Sciences in 2005 and a Ph.D. in
1157:
1106:
1055:
1004:
953:
902:
851:
793:
742:
691:
1147:
1137:
1096:
1086:
1045:
1035:
994:
984:
943:
933:
892:
882:
841:
833:
783:
773:
732:
722:
681:
671:
430:
86:
281:
54:
829:
1152:
1125:
1101:
1074:
1050:
1023:
999:
972:
948:
921:
897:
870:
846:
813:
788:
761:
737:
710:
686:
659:
111:
1175:
353:
212:
538:"UK vaccine volunteers to help prepare for next virus at new Pandemic Institute"
1142:
989:
938:
837:
727:
676:
887:
273:
160:
107:
357:
342:
312:
44:
1161:
1110:
1059:
1008:
957:
906:
855:
797:
746:
695:
24:
305:
258:
250:
215:. She is a specialist in bacterial infection, respiratory co-infection,
1091:
1040:
243:
156:
778:
319:
185:
611:
489:
323:
280:(São Paulo, Brazil). During her PhD, Ferreira was awarded the
516:"Oxford Covid vaccine 'safe and effective', Lancet study shows"
137:
Research on Respiratory Infections and Covid-19 Vaccine trials
18:
456:"BBC Radio Merseyside with LSTM's Professor Daniela Ferreira"
261:
vaccine studies including the Oxford / Astrazeneca vaccine.
589:
326:, aging, smoke) alters responses to pneumococcal infection
384:
Healthy Adults. Am J Respir Crit Care Med. 2013 Jan 31.
227:
and the Director of the Liverpool Vaccine Group at the
49:
39:
380:
Immunol. 2016 Jan;9(1):56-67. doi: 10.1038/mi.2015.35.
304:
1) Accelerate development and test novel pneumococcal
490:"Experimental Human Pneumococcal Carriage consortium"
287:Ferreira joined the Respiratory Infection group at
184:
166:
148:
133:
117:
103:
93:
77:
249:Discover how the host alters the biology of the
403:"Connecting immunology in the time of COVID-19"
376:Immunol. 2016 Aug 31. doi: 10.1038/mi.2016.71.
246:candidates and test new vaccines more rapidly
8:
284:Research Award in Pneumococcal Vaccinology.
235:Discover how people with risk factors (age,
358:https://doi.org/10.1038/s41467-019-10814-9
343:https://doi.org/10.1164/rccm.201903-0607OC
85:
74:
1151:
1141:
1100:
1090:
1049:
1039:
998:
988:
947:
937:
896:
886:
845:
787:
777:
736:
726:
685:
675:
484:
482:
480:
478:
476:
295:in December 2009 and together with Prof.
223:in the Department of Paediatrics at the
1197:21st-century Brazilian women scientists
394:
494:Liverpool School of Tropical Medicine
289:Liverpool School of Tropical Medicine
229:Liverpool School of Tropical Medicine
175:Liverpool School of Tropical Medicine
7:
425:
423:
14:
971:Ferreira, Pennington; SH (2016).
23:
869:Ferreira, Jochems; SP (2018).
1:
1124:Gordon, Ferreira; DM (2013).
1073:Ferreira, Glennie; S (2016).
920:Ferreira, Glennie; S (2019).
760:Ferreira, Jochems; S (2019).
431:"Professor Daniela Ferreira"
308:using experimental carriage
1022:Ferreira, Mitsi; E (2017).
709:Ferreira, Mitsi; E (2020).
658:Ferreira, Adler; H (2021).
368:10.1164/rccm.201811-2081LE.
153:Respiratory tract infection
1213:
1143:10.1164/rccm.201212-2277OC
990:10.1164/rccm.201512-2467OC
939:10.1164/rccm.201811-2081LE
838:10.1038/s41467-019-10814-9
728:10.1164/rccm.201903-0607OC
677:10.1164/rccm.202004-1483OC
1130:Am J Respir Crit Care Med
977:Am J Respir Crit Care Med
926:Am J Respir Crit Care Med
888:10.1038/s41590-018-0231-y
715:Am J Respir Crit Care Med
664:Am J Respir Crit Care Med
570:(in Brazilian Portuguese)
372:Dec 15;194(12):1523-1531.
253:while it is being carried
202:
141:
84:
1187:Brazilian immunologists
638:Imperial College London
278:University of São Paulo
276:in 2009, both from the
211:is a Brazilian British
127:University of São Paulo
122:University of São Paulo
38:, as no other articles
16:Brazilian immunologist
1192:Influenza researchers
818:Nature Communications
590:"HIC-VACc onsortium"
237:chronic lung disease
225:University of Oxford
221:Oxford Vaccine Group
171:University of Oxford
830:2019NatCo..10.2981D
544:. 12 September 2021
407:www.eventsforce.net
293:postdoctoral fellow
268:Research and career
209:Daniela M. Ferreira
98:Daniela M. Ferreira
79:Daniela M. Ferreira
1092:10.1038/mi.2015.35
1041:10.1038/mi.2016.71
217:mucosal immunology
179:Butantan institute
57:for suggestions.
47:to this page from
983:(12): 1523–1531.
881:(12): 1299–1308.
875:Nature Immunology
779:10.1172/JCI128865
772:(10): 4523–4538.
206:
205:
143:Scientific career
71:
70:
1204:
1166:
1165:
1155:
1145:
1121:
1115:
1114:
1104:
1094:
1070:
1064:
1063:
1053:
1043:
1019:
1013:
1012:
1002:
992:
968:
962:
961:
951:
941:
932:(9): 1160–1163.
917:
911:
910:
900:
890:
866:
860:
859:
849:
808:
802:
801:
791:
781:
757:
751:
750:
740:
730:
706:
700:
699:
689:
679:
655:
649:
648:
646:
644:
630:
624:
623:
621:
619:
608:
602:
601:
599:
597:
586:
580:
579:
577:
575:
560:
554:
553:
551:
549:
534:
528:
527:
525:
523:
512:
506:
505:
503:
501:
486:
471:
470:
468:
466:
452:
446:
445:
443:
441:
427:
418:
417:
415:
413:
399:
331:Key Publications
198:
89:
75:
66:
63:
52:
50:related articles
27:
19:
1212:
1211:
1207:
1206:
1205:
1203:
1202:
1201:
1172:
1171:
1170:
1169:
1123:
1122:
1118:
1079:Mucosal Immunol
1072:
1071:
1067:
1028:Mucosal Immunol
1021:
1020:
1016:
970:
969:
965:
919:
918:
914:
868:
867:
863:
810:
809:
805:
759:
758:
754:
708:
707:
703:
657:
656:
652:
642:
640:
632:
631:
627:
617:
615:
610:
609:
605:
595:
593:
588:
587:
583:
573:
571:
562:
561:
557:
547:
545:
536:
535:
531:
521:
519:
514:
513:
509:
499:
497:
488:
487:
474:
464:
462:
454:
453:
449:
439:
437:
429:
428:
421:
411:
409:
401:
400:
396:
391:
333:
282:Robert Austrian
270:
196:
177:
173:
125:
99:
80:
67:
61:
58:
48:
45:introduce links
28:
17:
12:
11:
5:
1210:
1208:
1200:
1199:
1194:
1189:
1184:
1174:
1173:
1168:
1167:
1136:(8): 855–864.
1116:
1065:
1034:(2): 385–394.
1014:
963:
912:
861:
803:
752:
721:(3): 335–347.
701:
670:(5): 604–613.
650:
625:
603:
581:
555:
529:
507:
472:
447:
419:
393:
392:
390:
387:
386:
385:
381:
377:
373:
369:
365:
361:
350:
346:
338:
332:
329:
328:
327:
316:
309:
297:Stephen Gordon
269:
266:
255:
254:
247:
240:
204:
203:
200:
199:
188:
182:
181:
168:
164:
163:
150:
146:
145:
139:
138:
135:
134:Known for
131:
130:
119:
115:
114:
105:
101:
100:
97:
95:
91:
90:
82:
81:
78:
69:
68:
55:Find link tool
31:
29:
22:
15:
13:
10:
9:
6:
4:
3:
2:
1209:
1198:
1195:
1193:
1190:
1188:
1185:
1183:
1182:Living people
1180:
1179:
1177:
1163:
1159:
1154:
1149:
1144:
1139:
1135:
1131:
1127:
1120:
1117:
1112:
1108:
1103:
1098:
1093:
1088:
1084:
1080:
1076:
1069:
1066:
1061:
1057:
1052:
1047:
1042:
1037:
1033:
1029:
1025:
1018:
1015:
1010:
1006:
1001:
996:
991:
986:
982:
978:
974:
967:
964:
959:
955:
950:
945:
940:
935:
931:
927:
923:
916:
913:
908:
904:
899:
894:
889:
884:
880:
876:
872:
865:
862:
857:
853:
848:
843:
839:
835:
831:
827:
823:
819:
815:
807:
804:
799:
795:
790:
785:
780:
775:
771:
767:
766:J Clin Invest
763:
756:
753:
748:
744:
739:
734:
729:
724:
720:
716:
712:
705:
702:
697:
693:
688:
683:
678:
673:
669:
665:
661:
654:
651:
639:
635:
629:
626:
613:
607:
604:
591:
585:
582:
569:
565:
559:
556:
543:
539:
533:
530:
517:
511:
508:
495:
491:
485:
483:
481:
479:
477:
473:
461:
457:
451:
448:
436:
432:
426:
424:
420:
408:
404:
398:
395:
388:
382:
378:
374:
370:
366:
362:
359:
355:
351:
347:
344:
339:
335:
334:
330:
325:
321:
317:
315:and bacteria
314:
310:
307:
303:
302:
301:
298:
294:
290:
285:
283:
279:
275:
267:
265:
262:
260:
252:
248:
245:
241:
238:
234:
233:
232:
230:
226:
222:
218:
214:
210:
201:
194:
193:
189:
187:
183:
180:
176:
172:
169:
165:
162:
158:
154:
151:
147:
144:
140:
136:
132:
128:
123:
120:
116:
113:
109:
106:
102:
96:
92:
88:
83:
76:
73:
65:
56:
51:
46:
42:
41:
37:
32:This article
30:
26:
21:
20:
1133:
1129:
1119:
1085:(1): 56–67.
1082:
1078:
1068:
1031:
1027:
1017:
980:
976:
966:
929:
925:
915:
878:
874:
864:
821:
817:
806:
769:
765:
755:
718:
714:
704:
667:
663:
653:
641:. Retrieved
637:
628:
618:15 September
616:. Retrieved
606:
596:15 September
594:. Retrieved
584:
572:. Retrieved
567:
558:
546:. Retrieved
542:the Guardian
541:
532:
522:15 September
520:. Retrieved
510:
500:15 September
498:. Retrieved
493:
463:. Retrieved
459:
450:
438:. Retrieved
434:
410:. Retrieved
406:
397:
286:
271:
263:
256:
213:immunologist
208:
207:
190:
167:Institutions
142:
72:
62:October 2021
59:
33:
824:(1): 2981.
242:Pre-select
104:Citizenship
1176:Categories
643:13 October
574:13 October
548:13 October
465:13 October
440:13 October
412:13 October
389:References
354:Bogaert D.
274:Immunology
161:Immunology
53:; try the
40:link to it
592:. HIV-VAC
313:SARS-CoV2
118:Education
108:Brazilian
43:. Please
1162:23370916
1111:25921341
1060:27579859
1009:27403678
958:30758980
907:30374129
856:31278315
798:31361601
747:31626559
696:32941735
306:vaccines
259:COVID-19
251:bacteria
1153:3707375
1102:4703943
1051:5332540
1000:5215029
949:6515882
898:6241853
847:6611866
826:Bibcode
789:6763269
738:6999099
687:7924584
612:"iicon"
244:vaccine
157:Vaccine
112:British
1160:
1150:
1109:
1099:
1058:
1048:
1007:
997:
956:
946:
905:
895:
854:
844:
796:
786:
745:
735:
694:
684:
614:. LSTM
518:. LSTM
496:. LSTM
320:asthma
197:(2009)
195:
186:Thesis
149:Fields
36:orphan
34:is an
291:as a
129:(PhD)
124:(SP)
1158:PMID
1107:PMID
1056:PMID
1005:PMID
954:PMID
903:PMID
852:PMID
794:PMID
743:PMID
692:PMID
645:2021
620:2021
598:2021
576:2021
550:2021
524:2021
502:2021
467:2021
460:LSTM
442:2021
435:LSTM
414:2021
324:COPD
159:and
110:and
94:Born
1148:PMC
1138:doi
1134:187
1097:PMC
1087:doi
1046:PMC
1036:doi
995:PMC
985:doi
981:194
944:PMC
934:doi
930:199
893:PMC
883:doi
842:PMC
834:doi
784:PMC
774:doi
770:129
733:PMC
723:doi
719:201
682:PMC
672:doi
668:203
364:29.
1178::
1156:.
1146:.
1132:.
1128:.
1105:.
1095:.
1081:.
1077:.
1054:.
1044:.
1032:10
1030:.
1026:.
1003:.
993:.
979:.
975:.
952:.
942:.
928:.
924:.
901:.
891:.
879:19
877:.
873:.
850:.
840:.
832:.
822:10
820:.
816:.
792:.
782:.
768:.
764:.
741:.
731:.
717:.
713:.
690:.
680:.
666:.
662:.
636:.
568:G1
566:.
540:.
492:.
475:^
458:.
433:.
422:^
405:.
322:,
155:,
1164:.
1140::
1113:.
1089::
1083:9
1062:.
1038::
1011:.
987::
960:.
936::
909:.
885::
858:.
836::
828::
800:.
776::
749:.
725::
698:.
674::
647:.
622:.
600:.
578:.
552:.
526:.
504:.
469:.
444:.
416:.
360:.
345:.
64:)
60:(
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
